TCL Archive NCA Approves Major Revision In Program Project Guidelines; Smaller, Tightly Focused Grants Seen May 27, 1983
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Oxford University Press Wins CRADA For Journal Of The National Cancer Istitute September 20, 1996
